<DOC>
	<DOCNO>NCT00412113</DOCNO>
	<brief_summary>The purpose study investigate whether aggressive multi-risk factor management strategy ( Caduet plus therapeutic lifestyle change ( TLC ) regimen ) result great percentage patient achieve blood pressure low density lipoprotein cholesterol ( LDL-C ) goal compare Joint National Committee 7/ National Cholesterol Education Program Adult Treatment Panel III ( JNC 7/NCEP ATP III ) guideline-based approach ( Norvasc plus TLC regimen ) 6 week treatment primary prevention subject hypertension additional risk factor , include dyslipidemia .</brief_summary>
	<brief_title>A Multi-Risk Factor Strategy vs Guideline-Based Approach Achieving Blood Pressure Lipid Goals Hypertensives Extra Risk</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine , atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Subjects diagnose hypertension receive treatment Norvasc 5 10 mg also 3 additional cardiovascular risk factor , include dyslipidemia . Subjects take follow prohibited medication within 14 day screen : lipidlowering therapy , calcium channel blocker Norvasc , &gt; 3 antihypertensive agent ( include Norvasc ) Subjects stable dose Norvasc least 4 week Subjects history coronary heart disease , stroke , Pulmonary Vascular Disease ( PVD )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>